 | • レポートコード：QYR2104Z4325 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、中咽頭がん診断治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（内視鏡検査、生検、イメージング）、用途別市場規模（病院、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・中咽頭がん診断治療の市場動向 ・企業の競争状況、市場シェア ・中咽頭がん診断治療の種類別市場規模（内視鏡検査、生検、イメージング） ・中咽頭がん診断治療の用途別市場規模（病院、外来手術センター） ・中咽頭がん診断治療の北米市場規模2016-2027（アメリカ、カナダ） ・中咽頭がん診断治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・中咽頭がん診断治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・中咽頭がん診断治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・中咽頭がん診断治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、GE Healthcare、Synta Pharmaceuticals、VLPbio、Novartis、Immunovaccine、Inovio Pharmaceuticals、AB Science、Bayer、Bristol-Myers Squibb、Boston Biomedical、AstraZeneca） ・結論 |
Market Analysis and Insights: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
The global Oropharyngeal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oropharyngeal Cancer Diagnosis and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oropharyngeal Cancer Diagnosis and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oropharyngeal Cancer Diagnosis and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oropharyngeal Cancer Diagnosis and Therapeutics market.
Global Oropharyngeal Cancer Diagnosis and Therapeutics Scope and Market Size
Oropharyngeal Cancer Diagnosis and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oropharyngeal Cancer Diagnosis and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Endoscopy
Biopsy
Imaging
Segment by Application
Hospitals
Ambulatory surgery centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
GE Healthcare
Synta Pharmaceuticals
VLPbio
Novartis
Immunovaccine
Inovio Pharmaceuticals
AB Science
Bayer
VLPbio
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Endoscopy
1.2.3 Biopsy
1.2.4 Imaging
1.3 Market by Application
1.3.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Perspective (2016-2027)
2.2 Oropharyngeal Cancer Diagnosis and Therapeutics Growth Trends by Regions
2.2.1 Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oropharyngeal Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Oropharyngeal Cancer Diagnosis and Therapeutics Industry Dynamic
2.3.1 Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends
2.3.2 Oropharyngeal Cancer Diagnosis and Therapeutics Market Drivers
2.3.3 Oropharyngeal Cancer Diagnosis and Therapeutics Market Challenges
2.3.4 Oropharyngeal Cancer Diagnosis and Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Revenue
3.1.1 Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue
3.4 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Concentration Ratio
3.4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in 2020
3.5 Oropharyngeal Cancer Diagnosis and Therapeutics Key Players Head office and Area Served
3.6 Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Product Solution and Service
3.7 Date of Enter into Oropharyngeal Cancer Diagnosis and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oropharyngeal Cancer Diagnosis and Therapeutics Breakdown Data by Type
4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027)
5 Oropharyngeal Cancer Diagnosis and Therapeutics Breakdown Data by Application
5.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
6.2 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type
6.2.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
6.3 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application
6.3.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
6.4 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country
6.4.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
7.2 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type
7.2.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application
7.3.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country
7.4.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
9.2 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type
9.2.1 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application
9.3.1 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country
9.4.1 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.1.4 Merck Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.1.5 Merck Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.2.4 GE Healthcare Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Synta Pharmaceuticals
11.3.1 Synta Pharmaceuticals Company Details
11.3.2 Synta Pharmaceuticals Business Overview
11.3.3 Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.3.4 Synta Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.3.5 Synta Pharmaceuticals Recent Development
11.4 VLPbio
11.4.1 VLPbio Company Details
11.4.2 VLPbio Business Overview
11.4.3 VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.4.4 VLPbio Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.4.5 VLPbio Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.5.4 Novartis Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Immunovaccine
11.6.1 Immunovaccine Company Details
11.6.2 Immunovaccine Business Overview
11.6.3 Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.6.4 Immunovaccine Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.6.5 Immunovaccine Recent Development
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Details
11.7.2 Inovio Pharmaceuticals Business Overview
11.7.3 Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.7.4 Inovio Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.7.5 Inovio Pharmaceuticals Recent Development
11.8 AB Science
11.8.1 AB Science Company Details
11.8.2 AB Science Business Overview
11.8.3 AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.8.4 AB Science Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.8.5 AB Science Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.9.4 Bayer Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.10.4 Bristol-Myers Squibb Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Boston Biomedical
11.11.1 Boston Biomedical Company Details
11.11.2 Boston Biomedical Business Overview
11.11.3 Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.11.4 Boston Biomedical Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.11.5 Boston Biomedical Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Introduction
11.12.4 AstraZeneca Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
11.12.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Endoscopy
Table 3. Key Players of Biopsy
Table 4. Key Players of Imaging
Table 5. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Table 11. Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends
Table 12. Oropharyngeal Cancer Diagnosis and Therapeutics Market Drivers
Table 13. Oropharyngeal Cancer Diagnosis and Therapeutics Market Challenges
Table 14. Oropharyngeal Cancer Diagnosis and Therapeutics Market Restraints
Table 15. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics as of 2020)
Table 18. Ranking of Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oropharyngeal Cancer Diagnosis and Therapeutics Product Solution and Service
Table 22. Date of Enter into Oropharyngeal Cancer Diagnosis and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Oropharyngeal Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 65. Merck Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. GE Healthcare Company Details
Table 68. GE Healthcare Business Overview
Table 69. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 70. GE Healthcare Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 71. GE Healthcare Recent Development
Table 72. Synta Pharmaceuticals Company Details
Table 73. Synta Pharmaceuticals Business Overview
Table 74. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 75. Synta Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Synta Pharmaceuticals Recent Development
Table 77. VLPbio Company Details
Table 78. VLPbio Business Overview
Table 79. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 80. VLPbio Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 81. VLPbio Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 85. Novartis Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Immunovaccine Company Details
Table 88. Immunovaccine Business Overview
Table 89. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 90. Immunovaccine Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Immunovaccine Recent Development
Table 92. Inovio Pharmaceuticals Company Details
Table 93. Inovio Pharmaceuticals Business Overview
Table 94. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 95. Inovio Pharmaceuticals Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Inovio Pharmaceuticals Recent Development
Table 97. AB Science Company Details
Table 98. AB Science Business Overview
Table 99. AB Science Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 100. AB Science Recent Development
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 104. Bayer Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. Bristol-Myers Squibb Company Details
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 109. Bristol-Myers Squibb Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. Boston Biomedical Company Details
Table 112. Boston Biomedical Business Overview
Table 113. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 114. Boston Biomedical Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Boston Biomedical Recent Development
Table 116. AstraZeneca Company Details
Table 117. AstraZeneca Business Overview
Table 118. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Product
Table 119. AstraZeneca Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021) & (US$ Million)
Table 120. AstraZeneca Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Endoscopy Features
Figure 3. Biopsy Features
Figure 4. Imaging Features
Figure 5. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory surgery centers Case Studies
Figure 8. Oropharyngeal Cancer Diagnosis and Therapeutics Report Years Considered
Figure 9. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Players in 2020
Figure 14. Global Top Oropharyngeal Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oropharyngeal Cancer Diagnosis and Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Oropharyngeal Cancer Diagnosis and Therapeutics Revenue in 2020
Figure 16. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Region (2016-2027)
Figure 38. China Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Oropharyngeal Cancer Diagnosis and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 58. GE Healthcare Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 59. Synta Pharmaceuticals Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 60. VLPbio Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 62. Immunovaccine Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 63. Inovio Pharmaceuticals Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 64. AB Science Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 65. Bayer Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 67. Boston Biomedical Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Oropharyngeal Cancer Diagnosis and Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…- 世界の結腸直腸がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Colorectal Cancer Diagnosis and Therapeutics Market The global Colorectal Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy i…
- 世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の骨肉腫診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Bone Cancer Diagnosis and Therapeutics Market The global Bone Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界の肺がん診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Lung Cancer Diagnosis and Therapeutics Market The global Lung Cancer Diagnosis and Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…